Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

NCT04437303 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT04437303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04437303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
Lead sponsor
St. Antonius Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 25, 2020
Completion date
May 22, 2024
Enrollment
858 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortic valve stenosis, bleeding, myocardial infarction, stroke, thrombosis embolism, vascular complications